Acme Universal Safezone 9 IPO Lists at 42% Premium — ₹101 on BSE

IPO Listing Reports 08 Oct 2026 3 min read

Acme Universal Safezone 9 IPO: A Stellar Debut on BSE SME!

Wow! What a day for investors who put their faith in Acme Universal Safezone 9! The SME IPO has just exploded onto the BSE, and let me tell you, the performance has been nothing short of spectacular. If you were one of the lucky ones to get an allotment, you’re probably celebrating right now. This isn’t just a listing; it’s a victory lap for smart investing and a testament to the potential brewing in our vibrant SME sector.

Issue Price ₹71
Listing Price ₹101
Closing Price ₹106.05
Listing Gain +42.3%
Subscription 31.3x
Type SME
View Full IPO Details →

Listing Performance

Let’s dive straight into the numbers, because they tell a thrilling story. Acme Universal Safezone 9 IPO listed at a fantastic ₹101 per share, a significant jump from its issue price of ₹71. That’s a whopping ₹30 gain per share, translating to an incredible 42% jump on day one! For those who invested in lots, the profit is substantial. With 1600 shares per lot, the profit per lot stands at a cool ₹48,000. Imagine that – a nearly 42% return on your investment on the very first day of trading! The market sentiment was clearly in favour of this offering, and the investor reaction has been overwhelmingly positive, with buyers rushing in to secure their stake in this promising company.

CategorySubscriptionProgress
Retail0.00x
NII / HNI0.00x
QIB31.29x
Total31.29x

Subscription vs Listing

Now, let’s talk about how the subscription levels predicted this stellar performance. Acme Universal Safezone 9 IPO was a runaway success in terms of demand, attracting an overwhelming subscription of 31.29 times. This level of oversubscription is a strong indicator of investor confidence, and as expected, it paved the way for a strong listing. Interestingly, the sheer volume of interest suggested that the listing would be positive, but the magnitude of the 42% gain has certainly impressed even the most seasoned market watchers. What stands out here is that the strong fundamentals and future prospects of Acme Universal Safezone 9 resonated deeply with investors, leading them to bid aggressively during the subscription period, and now, they’re reaping the rewards.

Key Takeaways

So, what can we all learn from this exhilarating debut of Acme Universal Safezone 9? Firstly, it underscores the immense potential of well-researched companies listed on the BSE SME platform. Don’t underestimate the power of these smaller enterprises; they can deliver substantial returns when the market recognizes their value. Secondly, high subscription levels are often a reliable predictor of a positive listing, especially when accompanied by a compelling business model and a clear growth strategy. However, it’s crucial to remember that past performance, while encouraging, is not a guarantee of future results. Investors should always conduct their due diligence, understand the company’s financials, and assess its long-term prospects before making any investment decisions. The bottom line is that Acme Universal Safezone 9 has set a high bar, and it’s a great reminder of the opportunities available in the Indian stock market for those who are informed and strategic.

For more in-depth information on Acme Universal Safezone 9’s IPO journey, you can View Acme Universal Safezone 9 IPO Details.

Acme Universal Safezone 9 Acme Universal Safezone 9 IPO GMP Today IPO 2026 IPO GMP IPO Listing Listing Gains